124 related articles for article (PubMed ID: 11883192)
1. Prolonged E55+ retrovirus expression in aged mice is associated with a decline in the anti-virus immune response.
elRefaei M; Blank KJ; Murasko DM
Virology; 2001 Nov; 290(2):281-9. PubMed ID: 11883192
[TBL] [Abstract][Full Text] [Related]
2. Decreased IL-2, IFN-gamma, and IL-10 production by aged mice during the acute phase of E55+ retrovirus infection.
Elrefaei M; Blank KJ; Murasko DM
Virology; 2002 Jul; 299(1):8-19. PubMed ID: 12167336
[TBL] [Abstract][Full Text] [Related]
3. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease.
Kawabata H; Niwa A; Tsuji-Kawahara S; Uenishi H; Iwanami N; Matsukuma H; Abe H; Tabata N; Matsumura H; Miyazawa M
Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628
[TBL] [Abstract][Full Text] [Related]
4. Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.
Messer RJ; Dittmer U; Peterson KE; Hasenkrug KJ
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12260-5. PubMed ID: 15297622
[TBL] [Abstract][Full Text] [Related]
5. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
6. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
7. High levels of IL-4 and IL-10 mRNA and low levels of IL-2, IL-9 and IFN-gamma mRNA in MuLV-induced lymphomas.
Beaty RM; Rulli K; Bost KL; Pantginis J; Lenz J; Levy LS
Virology; 1999 Sep; 261(2):253-62. PubMed ID: 10497110
[TBL] [Abstract][Full Text] [Related]
8. The role of the immune response in MULV-induced lymphomagenesis.
Marshall DJ; Gaulton GN
Leukemia; 1996 Dec; 10(12):1860-6. PubMed ID: 8946922
[TBL] [Abstract][Full Text] [Related]
9. Identification of a protective CD4+ T-cell epitope in p15gag of Friend murine leukemia virus and role of the MA protein targeting the plasma membrane in immunogenicity.
Sugahara D; Tsuji-Kawahara S; Miyazawa M
J Virol; 2004 Jun; 78(12):6322-34. PubMed ID: 15163726
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection.
Zelinskyy G; Kraft AR; Schimmer S; Arndt T; Dittmer U
Eur J Immunol; 2006 Oct; 36(10):2658-70. PubMed ID: 16981182
[TBL] [Abstract][Full Text] [Related]
11. Cuttine edge: T cells from aged mice are resistant to depletion early during virus infection.
Jiang J; Anaraki F; Blank KJ; Murasko DM
J Immunol; 2003 Oct; 171(7):3353-7. PubMed ID: 14500628
[TBL] [Abstract][Full Text] [Related]
12. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
13. Host genetic factors that control immune responses to retrovirus infections.
Miyazawa M; Tsuji-Kawahara S; Kanari Y
Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
[TBL] [Abstract][Full Text] [Related]
14. Neonate-primed CD8+ memory cells rival adult-primed memory cells in antigen-driven expansion and anti-viral protection.
Fadel SA; Cowell LG; Cao S; Ozaki DA; Kepler TB; Steeber DA; Sarzotti M
Int Immunol; 2006 Feb; 18(2):249-57. PubMed ID: 16418189
[TBL] [Abstract][Full Text] [Related]
15. Redistribution and modulation of Gross murine leukemia virus antigens induced by specific antibodies.
Ioachim HL; Sabbath M
J Natl Cancer Inst; 1979 Jan; 62(1):169-80. PubMed ID: 281570
[TBL] [Abstract][Full Text] [Related]
16. Influence of H-2 complex on susceptibility to infection by murine leukemia virus.
Tucker HSt ; Weens J; Tsichlis P; Schwartz RS; Khiroya R; Donnelly J
J Immunol; 1977 Apr; 118(4):1239-43. PubMed ID: 191531
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies.
Bayer W; Schimmer S; Hoffmann D; Dittmer U; Wildner O
Vaccine; 2008 Jan; 26(5):716-26. PubMed ID: 18160188
[TBL] [Abstract][Full Text] [Related]
18. Role of T-cell subsets in acute and persistent E-55+ murine leukemia virus infection in susceptible progressor and resistant long-term nonprogressor mouse strains. Women and Infants Transmission Study.
Avidan N; Sieck TG; Blank KJ
Clin Immunol Immunopathol; 1997 Dec; 85(3):282-8. PubMed ID: 9400628
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of subcellular fractions and molecular species of MuLV-induced tumors. II. Stimulation of syngeneic antitumor cell-mediated immune responses by subcellular fractions and molecular species of the Rauscher-virus-induced RBL5 tumor.
Kobrin BJ; Naor D; Klein BY
J Immunol; 1981 May; 126(5):1874-82. PubMed ID: 6260859
[No Abstract] [Full Text] [Related]
20. IFN-gamma production in response to neuropathogenic Cas-Br-M murine leukemia virus infection.
Sarzotti M; Gomes Mda P; Hoffman PM
Viral Immunol; 1993; 6(3):207-17. PubMed ID: 8292227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
